Pharmaceutical Technology's In the Lab eNewsletter
3M Drug Delivery Systems UK organization has revealed that it is relocating its R&D team to the Charnwood Campus, which is an officially designated Life Sciences Opportunity Zone in Loughborough, United Kingdom
In an April 1, 2019 press statement, 3M Drug Delivery Systems (DDS) UK organization has revealed that it is relocating its R&D team to the Charnwood Campus, which is an officially designated Life Sciences Opportunity Zone (LSOZ) in Loughborough, United Kingdom.
The new R&D site is located in more than 1300 m2 of laboratory space, which has been configured specifically for the development of inhalation therapies to treat respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The overhaul and modernization of the property took two years to complete.
“I’m delighted that 3M’s DDS Division has moved its R&D lab to Charnwood Campus. 3M’s work in the field of life sciences, producing pharmaceuticals and cutting-edge med tech, makes it one of the most innovative enterprises in Leicester and Leicestershire,” said Kevin Harris, chair, Leicester and Leicestershire Enterprise Partnership. “I’m particularly pleased that 3M is able to take advantage of Charnwood Campus’ dual designation as both an Enterprise Zone and the UK’s first Life Sciences Opportunity Zone. LSOZ status means greater collaboration between academia and industry, to drive forward the life-saving discoveries of tomorrow.”
“This move is very exciting because most of our incredible UK-based R&D team will now be working together closer than before to pursue groundbreaking innovations in the field of drug delivery technology,” added Silvia Perez, 3M DDS, president and general manager. “Improved collaboration, networking, and interaction between the business and R&D functions is beneficial to reaching our goals.”
Source: 3M
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.